Cognitive Testing of an Electronic Version of the Faces Pain Scale-Revised with Pediatric and Adolescent Sickle Cell Patients

Neehar Gupta (), April N. Naegeli, Diane M. Turner-Bowker, Emuella M. Flood, Lori Ellen Heath, Shelley M. Mays and Carlton Dampier
Additional contact information
Neehar Gupta: Eli Lilly and Company, Lilly Corporate Center
April N. Naegeli: Eli Lilly and Company, Lilly Corporate Center
Diane M. Turner-Bowker: ERT
Emuella M. Flood: ICON plc, Clinical Outcomes Assessments
Lori Ellen Heath: Eli Lilly and Company, Lilly Corporate Center
Shelley M. Mays: Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center
Carlton Dampier: Emory University School of Medicine, Children’s Healthcare of Atlanta

The Patient: Patient-Centered Outcomes Research, 2016, vol. 9, issue 5, No 7, 433-443

Abstract: Abstract Background Patient diaries and pain scales can capture the course and complications of pain managed at home in children. The Faces Pain Scale-Revised (FPS-R) is a validated scale showing reliability in children, but it has not been validated in children with sickle cell disease (SCD). Objective The purpose of this study was to evaluate comprehension and usability of an electronic modified version of the FPS-R among pediatric patients with SCD. Methods This was a cross-sectional, qualitative study involving in-person interviews with children/adolescents from the USA and their parents/legal guardians. Interviews involved cognitive debriefing and usability testing of the FPS-R. Results In total, 22 children with SCD aged 4–17 years participated. Children aged 4–6 were generally unable to demonstrate clear understanding of the FPS-R and its response scale. Overall, children aged ≥7 years understood the instrument and could complete it on the electronic device, although children aged 7–8 often needed assistance from the parent. Children aged 9–17 years were able to read and complete the instrument independently. Most participants considered the electronic device easy to use. Conclusions The FPS-R was shown to be a comprehensible and usable pain measure for children aged 7–17 with SCD and to be beneficial for future clinical studies.

Date: 2016
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s40271-016-0166-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:patien:v:9:y:2016:i:5:d:10.1007_s40271-016-0166-z

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40271

DOI: 10.1007/s40271-016-0166-z

Access Statistics for this article

The Patient: Patient-Centered Outcomes Research is currently edited by Christopher I. Carswell

More articles in The Patient: Patient-Centered Outcomes Research from Springer, International Academy of Health Preference Research
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().